{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T04:54:11Z","timestamp":1791176051611,"version":"4.1.0"},"reference-count":37,"publisher":"Oxford University Press (OUP)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.1093\/carcin\/bgq150","type":"journal-article","created":{"date-parts":[[2010,7,29]],"date-time":"2010-07-29T08:07:38Z","timestamp":1280390858000},"page":"1576-1583","source":"Crossref","is-referenced-by-count":128,"title":["EZH2 supports ovarian carcinoma cell invasion and\/or metastasis via regulation of TGF-\u03b21 and is a predictor of outcome in ovarian carcinoma patients"],"prefix":"10.1093","volume":"31","author":[{"given":"Zhi-Yue","family":"Rao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mu-Yan","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo-Fen","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Ru","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi-Juan","family":"Mai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Feng","family":"Hua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Ji","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai-Xia","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang-Chao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-Yuan","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Xin","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsiang-Fu","family":"Kung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2010,7,28]]},"reference":[{"key":"key\n\t\t\t\t20170521004347_bib1","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s004320000153","article-title":"Epidemiological and molecular aspects of ovarian cancer risk","volume":"127","author":"Runnebaum","year":"2001","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"key\n\t\t\t\t20170521004347_bib2","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3322\/canjclin.57.1.43","article-title":"Cancer statistics, 2007","volume":"57","author":"Jemal","year":"2007","journal-title":"CA Cancer J. Clin."},{"key":"key\n\t\t\t\t20170521004347_bib3","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1158\/1078-0432.CCR-07-1569","article-title":"Diagnostic markers for early detection of ovarian cancer","volume":"14","author":"Visintin","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"key\n\t\t\t\t20170521004347_bib4","first-page":"99","article-title":"Current diagnosis and treatment modalities for ovarian cancer","volume":"107","author":"Schwartz","year":"2002","journal-title":"Cancer Treat. Res."},{"key":"key\n\t\t\t\t20170521004347_bib5","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1177\/107155769400100302","article-title":"Pathogenesis of ovarian cancers","volume":"1","author":"Berchuck","year":"1994","journal-title":"J. Soc. Gynecol. Investig."},{"key":"key\n\t\t\t\t20170521004347_bib6","first-page":"6281","article-title":"Large-scale serial analysis of gene expression reveals genes differentially expressed in ovarian cancer","volume":"60","author":"Hough","year":"2000","journal-title":"Cancer Res."},{"key":"key\n\t\t\t\t20170521004347_bib7","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.mrfmmm.2008.07.010","article-title":"Roles of the EZH2 histone methyltransferase in cancer epigenetics","volume":"647","author":"Simon","year":"2008","journal-title":"Mutat. Res."},{"key":"key\n\t\t\t\t20170521004347_bib8","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1038\/nature01075","article-title":"The polycomb group protein EZH2 is involved in progression of prostate cancer","volume":"419","author":"Varambally","year":"2002","journal-title":"Nature"},{"key":"key\n\t\t\t\t20170521004347_bib9","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.oraloncology.2008.03.016","article-title":"High expression of EZH2 is associated with tumor proliferation and prognosis in human oral squamous cell carcinomas","volume":"45","author":"Kidani","year":"2009","journal-title":"Oral Oncol."},{"key":"key\n\t\t\t\t20170521004347_bib10","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1002\/ijc.25031","article-title":"High expression of EZH2 is associated with tumor aggressiveness and poor prognosis in patients with esophageal squamous cell carcinoma treated with definitive chemoradiotherapy","volume":"127","author":"He","year":"2010","journal-title":"Int. J. Cancer"},{"key":"key\n\t\t\t\t20170521004347_bib11","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1111\/j.1349-7006.2006.00203.x","article-title":"Expression of the enhancer of zeste homolog 2 is correlated with poor prognosis in human gastric cancer","volume":"97","author":"Matsukawa","year":"2006","journal-title":"Cancer Sci."},{"key":"key\n\t\t\t\t20170521004347_bib12","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.ejso.2004.11.001","article-title":"Clinical significance of enhancer of zeste homolog 2 expression in colorectal cancer cases","volume":"31","author":"Mimori","year":"2005","journal-title":"Eur. J. Surg. Oncol."},{"key":"key\n\t\t\t\t20170521004347_bib13","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1038\/sj.bjc.6602531","article-title":"Clinicopathological significance of EZH2 mRNA expression in patients with hepatocellular carcinoma","volume":"92","author":"Sudo","year":"2005","journal-title":"Br. J. Cancer"},{"key":"key\n\t\t\t\t20170521004347_bib14","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1158\/1078-0432.CCR-05-1533","article-title":"Expression of enhancer of zeste homologue 2 is significantly associated with increased tumor cell proliferation and is a marker of aggressive breast cancer","volume":"12","author":"Collett","year":"2006","journal-title":"Clin. Cancer Res."},{"key":"key\n\t\t\t\t20170521004347_bib15","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1200\/JCO.2005.01.5180","article-title":"EZH2 expression is associated with high proliferation rate and aggressive tumor subgroups in cutaneous melanoma and cancers of the endometrium, prostate, and breast","volume":"24","author":"Bachmann","year":"2006","journal-title":"J. Clin. Oncol."},{"key":"key\n\t\t\t\t20170521004347_bib16","doi-asserted-by":"crossref","first-page":"8570","DOI":"10.1158\/1078-0432.CCR-05-1047","article-title":"Increased expression of the polycomb group gene, EZH2, in transitional cell carcinoma of the bladder","volume":"11","author":"Raman","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"key\n\t\t\t\t20170521004347_bib17","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1002\/hep.21668","article-title":"Lentivirus-mediated RNA interference targeting enhancer of zeste homolog 2 inhibits hepatocellular carcinoma growth through down-regulation of stathmin","volume":"46","author":"Chen","year":"2007","journal-title":"Hepatology"},{"key":"key\n\t\t\t\t20170521004347_bib18","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1002\/ijc.11514","article-title":"Heterogeneous expression and association of beta-catenin, p16 and c-myc in multistage colorectal tumorigenesis and progression detected by tissue microarray","volume":"107","author":"Xie","year":"2003","journal-title":"Int. J. Cancer"},{"key":"key\n\t\t\t\t20170521004347_bib19","doi-asserted-by":"crossref","first-page":"6504","DOI":"10.1158\/0008-5472.CAN-05-0351","article-title":"Oncogenic transformation by SEI-1 is associated with chromosomal instability","volume":"65","author":"Tang","year":"2005","journal-title":"Cancer Res."},{"key":"key\n\t\t\t\t20170521004347_bib20","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1159\/000084614","article-title":"Biological relevance of E-cadherin-catenin complex proteins in primary epithelial ovarian tumours","volume":"60","author":"Faleiro-Rodrigues","year":"2005","journal-title":"Gynecol. Obstet. Invest."},{"key":"key\n\t\t\t\t20170521004347_bib21","author":"Bolat","year":"2010"},{"key":"key\n\t\t\t\t20170521004347_bib22","first-page":"151","article-title":"Polycomb repression: from cellular memory to cellular proliferation and cancer","volume":"1602","author":"Jacobs","year":"2002","journal-title":"Biochim. Biophys. Acta"},{"key":"key\n\t\t\t\t20170521004347_bib23","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.gde.2004.02.001","article-title":"The functions of E(Z)\/EZH2-mediated methylation of lysine 27 in histone H3","volume":"14","author":"Cao","year":"2004","journal-title":"Curr. Opin. Genet. Dev."},{"key":"key\n\t\t\t\t20170521004347_bib24","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1046\/j.1365-2141.2001.02641.x","article-title":"The Polycomb group protein EZH2 is upregulated in proliferating, cultured human mantle cell lymphoma","volume":"112","author":"Visser","year":"2001","journal-title":"Br. J. Haematol."},{"key":"key\n\t\t\t\t20170521004347_bib25","doi-asserted-by":"crossref","first-page":"11606","DOI":"10.1073\/pnas.1933744100","article-title":"EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells","volume":"100","author":"Kleer","year":"2003","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"key\n\t\t\t\t20170521004347_bib26","doi-asserted-by":"crossref","first-page":"5323","DOI":"10.1093\/emboj\/cdg542","article-title":"EZH2 is downstream of the pRB-E2F pathway, essential for proliferation and amplified in cancer","volume":"22","author":"Bracken","year":"2003","journal-title":"EMBO J."},{"key":"key\n\t\t\t\t20170521004347_bib27","doi-asserted-by":"crossref","first-page":"6269","DOI":"10.1038\/sj.onc.1208771","article-title":"The polycomb group protein enhancer of zeste homolog 2 (EZH 2) is an oncogene that influences myeloma cell growth and the mutant ras phenotype","volume":"24","author":"Croonquist","year":"2005","journal-title":"Oncogene"},{"key":"key\n\t\t\t\t20170521004347_bib28","doi-asserted-by":"crossref","first-page":"5759","DOI":"10.1038\/sj.onc.1207706","article-title":"Activated p53 suppresses the histone methyltransferase EZH2 gene","volume":"23","author":"Tang","year":"2004","journal-title":"Oncogene"},{"key":"key\n\t\t\t\t20170521004347_bib29","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.4161\/cc.5.16.3222","article-title":"Essential role for activation of the Polycomb group (PcG) protein chromatin silencing pathway in metastatic prostate cancer","volume":"5","author":"Berezovska","year":"2006","journal-title":"Cell Cycle"},{"key":"key\n\t\t\t\t20170521004347_bib30","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1101\/gad.1524107","article-title":"Pharmacologic disruption of Polycomb-repressive complex 2-mediated gene repression selectively induces apoptosis in cancer cells","volume":"21","author":"Tan","year":"2007","journal-title":"Genes Dev."},{"key":"key\n\t\t\t\t20170521004347_bib31","doi-asserted-by":"crossref","first-page":"7274","DOI":"10.1038\/onc.2008.333","article-title":"Repression of E-cadherin by the polycomb group protein EZH2 in cancer","volume":"27","author":"Cao","year":"2008","journal-title":"Oncogene"},{"key":"key\n\t\t\t\t20170521004347_bib32","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1111\/j.1349-7006.2008.00743.x","article-title":"Enhancer of zeste homolog 2 downregulates E-cadherin by mediating histone H3 methylation in gastric cancer cells","volume":"99","author":"Fujii","year":"2008","journal-title":"Cancer Sci."},{"key":"key\n\t\t\t\t20170521004347_bib33","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1111\/j.1349-7006.2001.tb01123.x","article-title":"Overexpression of latent transforming growth factor-beta 1 (TGF-beta 1) binding protein 1 (LTBP-1) in association with TGF-beta 1 in ovarian carcinoma","volume":"92","author":"Higashi","year":"2001","journal-title":"Jpn. J. Cancer Res."},{"key":"key\n\t\t\t\t20170521004347_bib34","first-page":"804","article-title":"Increased levels of interleukin-10 and transforming growth factor-beta in the plasma and ascitic fluid of patients with advanced ovarian cancer","volume":"108","author":"Santin","year":"2001","journal-title":"BJOG"},{"key":"key\n\t\t\t\t20170521004347_bib35","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1023\/A:1011888126865","article-title":"TGFbeta1 stimulates the secretion of matrix metalloproteinase 2 (MMP2) and the invasive behavior in human ovarian cancer cells, which is suppressed by MMP inhibitor BB3103","volume":"18","author":"Lin","year":"2000","journal-title":"Clin. Exp. Metastasis"},{"key":"key\n\t\t\t\t20170521004347_bib36","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1158\/1541-7786.MCR-07-0294","article-title":"Transforming growth factor-beta1, transforming growth factor-beta2, and transforming growth factor-beta3 enhance ovarian cancer metastatic potential by inducing a Smad3-dependent epithelial-to-mesenchymal transition","volume":"6","author":"Do","year":"2008","journal-title":"Mol. Cancer Res."},{"key":"key\n\t\t\t\t20170521004347_bib37","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/(SICI)1097-0215(19960328)66:1<91::AID-IJC16>3.0.CO;2-E","article-title":"Epithelial-mesenchymal transformation of a newly established cell line from ovarian adenosarcoma by transforming growth factor-beta1","volume":"66","author":"Kitagawa","year":"1996","journal-title":"Int. J. Cancer"}],"container-title":["Carcinogenesis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/carcin\/article-pdf\/31\/9\/1576\/17290354\/bgq150.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,31]],"date-time":"2019-05-31T23:47:04Z","timestamp":1559346424000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/carcin\/article-lookup\/doi\/10.1093\/carcin\/bgq150"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7,28]]},"references-count":37,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2010,7,28]]},"published-print":{"date-parts":[[2010,9]]}},"URL":"https:\/\/doi.org\/10.1093\/carcin\/bgq150","relation":{},"ISSN":["1460-2180","0143-3334"],"issn-type":[{"value":"1460-2180","type":"electronic"},{"value":"0143-3334","type":"print"}],"subject":[],"published":{"date-parts":[[2010,7,28]]}}}